OpenAlex
PricingAboutJobs
Log inGet started
Author

C. Cheng

Institution: Eli Lilly (United States)
Observed institution: Eli Lilly (United States)
OpenAlex ID: A5114034356
The effects of LY2189265, a long‐acting glucagon‐like peptide‐1 analogue, in a randomized, placebo‐controlled, double‐blind study of overweight/obese patients with type 2 diabetes: the EGO study
2011 · G. E. Umpierrez, T. Blevins, et al. · Diabetes Obesity and Metabolism · 87
KGF induces TGFα expression and activates the EGF receptor signaling pathway to alter keratinocyte growth and differentiation in vitro
1993 · A.A. Dlugosz, C. Cheng, et al. · Journal of Dermatological Science · 2
Effect of LY2189265, a long-acting glucagon-like peptide 1 analog, on metabolic outcomes and GI events in obese patients with uncontrolled type 2 diabetes mellitus (T2DM): The EGo study.
2009 · G. Umpierrez, T. Blevins, et al. · Canadian Journal of Diabetes · 1
Involvement of cholinergic receptor in dorsal facial area for regulation of common carotid arterial blood flow in cats
2004 · 龔志力, Y. T. Chiu, et al.
Works count: 4
Citation count: 90
H-index: 2
I10-index: 1
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security